Last reviewed · How we verify
Placebo (for flucloxacillin)
A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and psychophysiological processes.
A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and psychophysiological processes. Used for Control comparator in clinical research (not a therapeutic indication).
At a glance
| Generic name | Placebo (for flucloxacillin) |
|---|---|
| Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebo is an inert substance used as a control in clinical trials and research settings. It works through expectation, conditioning, and the placebo effect rather than through direct molecular action. In this context, it was used as a comparator in a flucloxacillin study conducted by AMC-UvA.
Approved indications
- Control comparator in clinical research (not a therapeutic indication)
Common side effects
Key clinical trials
- Cellulitis Optimal Antibiotic Treatment (PHASE3)
- Adjunctive Clindamycin for Cellulitis: C4C Trial. (PHASE4)
- Duration of ANtibiotic Therapy for CEllulitis (PHASE4)
- Penicillin for the Emergency Department Outpatient Treatment of CELLulitis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: